gevokizumab
ravulizumab
ozoralizumab
tislelizumab
lenzilumab
Rh-positive blood type
brolucizumab
pidilizumab
Rh positive
counterimmune
olaratumab
pathoantigen
certolizumab
Duffy antigen
immunovaccine
belimumab
talizumab
preimmune
immunoabsorbent
interhombomeric
bezlotoxumab
rhabdomyoblastic
immunoagglutination
perakizumab
soravtansine
immunospecific
rheopectic
-axo-
immunodeposit
Rhesus factor
agonistic monoclonal antibody
fontolizumab
rheotactic
rhopalid
antiglucagon
histocompatibility antigen
vepalimomab
immunome
antigenically
immunize
immunonaive
conatumumab
inflammasome
inflammosuppression
-o-
idiospecific
immunoprevention
isoantibody
countercorrelated